| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/17/2011 | WO2011019956A2 Pharmaceutical compositions |
| 02/17/2011 | WO2011019821A2 METHOD FOR MAKING 3α-HYDROXY, 3β- METHYL-5α-PREGNAN-20-ONE (GANAXOLONE) |
| 02/17/2011 | WO2011019681A1 Selective sphingosine-1-phosphate receptor antagonists |
| 02/17/2011 | WO2011019124A1 Agmatine as an agent for enhancing stem cell efficacy |
| 02/17/2011 | WO2011019090A1 Pyrimidone derivatives used as tau protein kinase 1 inhibitors |
| 02/17/2011 | WO2011019089A1 Pyrimidone derivatives used as tau protein kinase 1 inhibitors |
| 02/17/2011 | WO2011019023A1 Agent for ameliorating blood-brain barrier disorders |
| 02/17/2011 | WO2011018894A1 Pyrrolopyrimidine derivatives as potassium channel modulators |
| 02/17/2011 | WO2011018588A2 Fgf receptor-activating n-acyl octasaccharides, preparation thereof, and therapeutic use thereof |
| 02/17/2011 | WO2011018587A2 Fgf receptor-activating n-sulfate oligosaccharides, preparation thereof, and therapeutic use thereof |
| 02/17/2011 | WO2011018495A1 New compounds for the treatment of cns disorders |
| 02/17/2011 | WO2011018488A1 Sigma ligands for the prevention or treatment of pain induced by chemotherapy |
| 02/17/2011 | WO2011018487A1 Sigma ligands for the prevention or treatment of pain induced by chemotherapy |
| 02/17/2011 | WO2011018417A1 Inhibitors of jnk |
| 02/17/2011 | WO2011017915A1 Method for repairing neurodegeneration |
| 02/17/2011 | WO2011017905A1 Use of senkyunolide i in manufacture of medicament for anti-depression, treating migraine and other diseases related to serotonergic system |
| 02/17/2011 | WO2010149164A3 Apparatus and method for pulsed electrical field treatment |
| 02/17/2011 | WO2010138828A3 Potassium channel modulators |
| 02/17/2011 | WO2010129674A3 Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins |
| 02/17/2011 | WO2010126635A3 Biomarkers of hemorrhagic shock |
| 02/17/2011 | WO2010123959A3 2,5-disubstituted arylsulfonamide ccr3 antagonists |
| 02/17/2011 | WO2010122980A8 NOVEL THYROID HORMONE β RECEPTOR AGONIST |
| 02/17/2011 | WO2010117979A3 Serotonin and norepinephrine reuptake inhibitor |
| 02/17/2011 | WO2010115125A3 Composition of 2,4,6-trifluoro-n-[6-(1-methyl-piperidin-4-carbonyl)-pyridin-2-yl]-benzamide |
| 02/17/2011 | WO2010091399A9 Reelin rescues cognitive function |
| 02/17/2011 | WO2010088409A3 Methods of neuroprotection using neuroprotective steroids and a vitamin d |
| 02/17/2011 | US20110040249 Human Anti-IL-23 Antibodies, Compositions, Methods and Uses |
| 02/17/2011 | US20110040240 Methods for treating rhinitis and conjunctivitis |
| 02/17/2011 | US20110040144 Method and apparatus for weight control by olfactory nerve ablation |
| 02/17/2011 | US20110039942 Titration package |
| 02/17/2011 | US20110039934 Process for the preparation of derivatives of 1-(2- halobiphenyl-4-yl)-cyclopropanecarboxylic acid |
| 02/17/2011 | US20110039929 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
| 02/17/2011 | US20110039926 Use of enantiomer (1s, 2r) milnacipran hydrochloride for the preventive treatment of suicidal behaviour in depressed patients |
| 02/17/2011 | US20110039925 Cyclobutyl sulfones as notch sparing gamma secretase inhibitors |
| 02/17/2011 | US20110039920 Inhibitors of ikk-beta serine-theronine protein kinase |
| 02/17/2011 | US20110039919 Pharmaceutical compositions for inhibiting angiogenesis |
| 02/17/2011 | US20110039913 Antisense modulation of hydroxysteroid 11-beta dehydrogenase 1 expression |
| 02/17/2011 | US20110039911 METHOD OF INHIBITING NONSENSE-MEDIATED mRNA DECAY |
| 02/17/2011 | US20110039908 Inhibiting Amyloid-Beta Peptide/Rage Interaction At The Blood-Brain Barrier |
| 02/17/2011 | US20110039903 Acute Pharmacologic Augmentation of Psychotherapy with Enhancers of Learning or Conditioning |
| 02/17/2011 | US20110039902 PROCESS FOR PREPARING A CRYSTALLINE FORM COMPOUND OF 3-BENZYL-2-METHYL-2,3,3a,4,5,6,7,7a-OCTAHYDROBENZO[d]ISOXAZOL-4-ONE |
| 02/17/2011 | US20110039901 PROCESS FOR PREPARING A CRYSTALLINE FORM COMPOUND OF 3-BENZYL-2-METHYL-2,3,3a,4,5,6,7,7a-OCTAHYDROBENZO[d]ISOXAZOL-4-ONE |
| 02/17/2011 | US20110039896 Novel 2-pyrrolidinyl-3-amido-6-amino-pyridine derivatives useful as potassium channel activators |
| 02/17/2011 | US20110039893 Gsk-3beta inhibitor |
| 02/17/2011 | US20110039890 4-[2,3-Difluoro-6-(2-fluoro-4-methyl-phenylsulfanyl)-phenyl]-piperidine |
| 02/17/2011 | US20110039888 Asymmetric alpha functionalization and alpha, alpha bisfunctionalization of aldehydes and ketones |
| 02/17/2011 | US20110039882 Phosphodiesterase 10a inhibitor |
| 02/17/2011 | US20110039881 Compositions and methods for treating middle-of-the-night insomnia |
| 02/17/2011 | US20110039877 Use of 3, 11b-cis-dihydrotetrabenazine in the treatment of multiple sclerosis and autoimmune myelitis |
| 02/17/2011 | US20110039875 Pharamaceutical compositions for treating chronic pain and pain associated with neuropathy |
| 02/17/2011 | US20110039874 Monoacylglycerol lipase inhibitors for modulation of cannabinoid activity |
| 02/17/2011 | US20110039873 SUBSTITUTED PYRAZOLO[1,5-a] PYRIDINE COMPOUNDS HAVING MULTI-TARGET ACTIVITY |
| 02/17/2011 | US20110039870 Tetrahydro-pyrazolo[1,5-a]pyrido-pyrimidines as antagonists of serotonin 5-ht6 receptors, methods for the production and use thereof |
| 02/17/2011 | US20110039869 Composition for inhibiting the activity of inositol 1,4,5-triphosphate receptor subtype iii |
| 02/17/2011 | US20110039866 Selective sphingosine-1-phosphate receptor antagonists |
| 02/17/2011 | US20110039858 Novel Compounds |
| 02/17/2011 | US20110039857 Piperidine and pyroolidine compounds |
| 02/17/2011 | US20110039840 Spirocyclic derivatives as histone deacetylase inhibitors |
| 02/17/2011 | US20110039835 Substituted arylamide diazepinopyrimidone derivatives |
| 02/17/2011 | US20110039834 Novel pharmaceutical compositions for optimizing substitution treatments and extending the pharmacopoeia to global treatment of addictions |
| 02/17/2011 | US20110039833 1-benzoyl substituted diazepine derivatives as selective histamine h3 receptor agonists |
| 02/17/2011 | US20110039828 Tetrahydroquinoline derivatives and a process for preparing the same |
| 02/17/2011 | US20110039825 Ligands of alpha-adrenoceptors, dopamine, histamine, imidazoline and serotonin receptors and their use |
| 02/17/2011 | US20110039818 Dosage regimen of an S1P receptor agonist |
| 02/17/2011 | US20110039807 Anti-parkinsonian compound acetylsalicylic acid maltol ester |
| 02/17/2011 | US20110039806 Combined therapies of antipsychotic drugs and tetracyclines in the treatment of psychiatric disorders |
| 02/17/2011 | US20110039801 Nk1 receptor antagonist composition |
| 02/17/2011 | US20110039800 Prolonged release bioadhesive therapeutic systems |
| 02/17/2011 | US20110039799 A1 adenosine receptor agonist polymorphs |
| 02/17/2011 | US20110039786 Metastin derivative and use thereof |
| 02/17/2011 | US20110039785 Polypeptide-nucleic acid conjugates and uses thereof |
| 02/17/2011 | US20110039774 Method for repairing neurodegeneration |
| 02/17/2011 | US20110039772 Novel uses of vegfxxxb |
| 02/17/2011 | US20110039771 Small humanin-like peptides |
| 02/17/2011 | US20110038969 Fermented composition of mung bean hulls, method for forming thereof, and anti-oxidation and anti-inflammation composition using the same |
| 02/17/2011 | US20110038958 Use of cannabinoids in combination with an anti-psychotic medicament |
| 02/17/2011 | US20110038957 Novel nutraceutical compositions containing stevia extract or stevia extract constituents and uses thereof |
| 02/17/2011 | US20110038953 Strontium compound for treatment of sub-dermal soft tissue pain |
| 02/17/2011 | US20110038949 Homeopathic formulation |
| 02/17/2011 | US20110038930 Hot-melt extruded pharmaceutical dosage form |
| 02/17/2011 | US20110038928 Orally disintegrating tablets of zolmitriptan |
| 02/17/2011 | US20110038927 Controlled release hydrocodone formulations |
| 02/17/2011 | US20110038925 Intravenous formulations of neurokinin-1 antagonists |
| 02/17/2011 | US20110038915 Chewing Gum Formula for Enhancing Psycho-Spirituality |
| 02/17/2011 | US20110038903 Apparatus and Process for Generating and Harvesting Adult Stem Cells and Fluid Associated with it from Skin and Omentum for Medical, Cosmetic, and Veterinary Use |
| 02/17/2011 | US20110038897 Oral controlled release formulations |
| 02/17/2011 | US20110038893 Therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy |
| 02/17/2011 | US20110038889 Methods and compositions for altering cell function |
| 02/17/2011 | US20110038872 Methods of diagnosing and treating autism |
| 02/17/2011 | US20110038861 Methods of Treating Alzheimer's Disease Using Antibodies Directed Against Amyloid Beta Peptide and Compositions Thereof |
| 02/17/2011 | US20110038855 Trail and methods of modulating t cell activity and adaptive immune responses using trail |
| 02/17/2011 | US20110038851 Treatment of synucleinopathies |
| 02/17/2011 | US20110038850 G Protein-Coupled Receptor and Modulators Thereof For The Treatment of Gaba-Related Neurological Disorders Including Sleep-Related Disorders |
| 02/17/2011 | US20110038836 Device and Method for Transfecting Cells for Therapeutic Use |
| 02/17/2011 | US20110038835 Anilides and analogs as rho kinase inhibitors |
| 02/17/2011 | US20110038790 Treatment and prophylaxis of amyloidosis |
| 02/17/2011 | CA2771539A1 Pharmaceutical compositions with tetrabenzine |
| 02/17/2011 | CA2771203A1 Treatment of bdnf-related disorders using laquinimod |
| 02/17/2011 | CA2771083A1 Selective sphingosine-1-phosphate receptor antagonists |
| 02/17/2011 | CA2771056A1 Fgf receptor-activating n-acyl octasaccharides, preparation thereof, and therapeutic use thereof |